Neuronal and glial alterations in the cerebellar cortex of maternally deprived rats: Gender differences and modulatory effects of two inhibitors of endocannabinoid inactivation

Developmental Neurobiology

Volumn 68, Issue 12, 2008, Pages 1429-1440

  Lopez Gallardo M ^a   Llorente, R ^a   Llorente Berzal, A ^a   Marco, E M ^a   Prada, C ^a   Di Marzo, V ^b   Viveros, M P ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b CNR   (Italy)

Author keywords

Cerebellum; Degenerative changes; Early maternal deprivation; Endocannabinoid system; Gender dependent effects

Indexed keywords

CANNABINOID RECEPTOR ANTAGONIST; ENDOCANNABINOID; FATTY ACID AMIDASE INHIBITOR; GLIAL FIBRILLARY ACIDIC PROTEIN; N [1 (4 HYDROXYPHENYL) 2 HYDROXYETHYL]OLEAMIDE; N ARACHIDONOYLSEROTONIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN NERVE CELL; CEREBELLUM CORTEX; DEGENERATIVE DISEASE; ENZYME INACTIVATION; FEMALE; FLUORESCENCE ANALYSIS; GLIA CELL; IMMUNOHISTOCHEMISTRY; MALE; MATERNAL DEPRIVATION; MENTAL DISEASE; NERVE DEGENERATION; NEUROMODULATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; SEXUAL DEVELOPMENT;

AMIDOHYDROLASES; ANIMALS; ANIMALS, NEWBORN; ARACHIDONIC ACIDS; ASTROCYTES; BENZYL COMPOUNDS; CEREBELLAR CORTEX; ENDOCANNABINOIDS; FEMALE; FLUORESCENT DYES; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; INJECTIONS, SUBCUTANEOUS; MALE; MATERNAL DEPRIVATION; NEUROGLIA; NEURONS; ORGANIC CHEMICALS; RATS; RATS, WISTAR; SEROTONIN; SEX FACTORS;

EID: 53049083678     PISSN: 00223034     EISSN: 10974695     Source Type: Journal    
DOI: 10.1002/dneu.20672     Document Type: Article

References (57)

1. Altman J. 1969. Autoradiographic and histological studies of postnatal neurogenesis. III. Dating the time of production and onset of differentiation of cerebellar microneurons in rats. J Comp Neurol 136:269-293.
2. Amaral DG, Schumann CM, Nordahl CW. 2008. Neuroanatomy of autism. Trends Neurosci 31:137-145.
3. Andreasen NC, Pierson R. 2008. The role of the cerebellum in schizophrenia. Biol Psychiatry 64:81-88.
4. Anezary L, Medina JI, Sanchez-Nogueiro J, Lopez-Gallardo M, Prada C. 2001. Shape diversity among chick retina Muller cells and their postnatal differentiation. J Comp Neurol 438:32-49.
5. Azcoitia I, Sierra A, Veiga S, Garcia-Segura LM. 2003. Aromatase expression by reactive astroglia is neuroprotective. Ann N Y Acad Sci 1007:298-305.
6. Bahr BA, Karanian DA, Makanji SS, Makriyannis A. 2006. Targeting the endocannabinoid system in treating brain disorders. Expert Opin Investig Drugs 15:351-365.
7. Becker EBE, Bonni A. 2004. Cell cycle regulation of neuronal apoptosis in development and disease. Prog Neurobiol 72:1-25.
8. Benito C, Kim WK, Chavarria I, Hillard CJ, Mackie K, Tolon RM, Williams K, et al. 2005. A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis. J Neurosci 25:2530-2536.
9. Berghuis P, Rajnicek AM, Morozov YM, Ross RA, Mulder J, Urban GM, Monory K, et al. 2007. Hardwiring the brain: Endocannabinoids shape neuronal connectivity. Science 316:1212-1216.
10. Bernard C, Milh M, Morozov YM, Ben Ari Y, Freund TF, Gozlan H. 2005. Altering cannabinoid signaling during development disrupts neuronal activity. Proc Natl Acad Sci USA 102:9388-9393.
11. Bisogno T, Berrendero F, Ambrosino G, Cebeira M, Ramos JA, Fernandez-Ruiz JJ, Di Marzo V. 1999. Brain regional distribution of endocannabinoids: Implications for their biosynthesis and biological function. Biochem Biophys Res Commun 256:377-380.
12. Bonthius DJ, West JR. 1991. Permanent neuronal deficits in rats exposed to alcohol during brain growth spurt. Teratology 44:147-163.
13. D'Argenio G, Valenti M, Scaglione G, Cosenza V, Sorrentini I, Di Marzo V. 2006. Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation. FASEB J 20:568-570.
14. Darnaudéry M, Maccari S. 2008. Epigenetic programming of the stress response in male and female rats by prenatal restraint stress. Brain Res Rev 57:571-585.
15. Davies W, Wilkinson LS. 2006. It is not all hormones: Alternative explanations for sexual differentiation of the brain. Brain Res 1126:36-45.
16. De Lago E, Petrosino S, Valenti M, Morera E, Ortega-Gutierrez S, Fernandez-Ruiz J, Di Marzo V. 2005. Effect of repeated systemic administration of selective inhibitors of endocannabinoid inactivation on rat brain endocannabinoid levels. Biochem Pharmacol 70:446-452.
17. Dean SL, McCarthy MM. 2008. Steroids, sex and the cerebellar cortex: Implications for human disease. Cerebellum 7:38-47.
18. Ellenbroek BA, Cools AR. 2002. Early maternal deprivation and prepulse inhibition: The role of the postdeprivation environment. Pharmacol Biochem Behav 73:177-184.
19. Ellenbroek BA, de Bruin NM, van Den Kroonenburg PT, van Luijtelaar EL, Cools AR. 2004. The effects of early maternal deprivation on auditory information processing in adult Wistar rats. Biol Psychiatry 55:701-707.
20. Ellenbroek BA, Derks N, Park HJ. 2005. Early maternal deprivation retards neurodevelopment in Wistar rats. Stress 8:247-257.
21. Ellenbroek BA, Riva MA. 2003. Early maternal deprivation as an animal model for schizophrenia. Clin Neurosci Res 3:297-302.
22. Ellenbroek BA, van den Kroonenberg PT, Cools AR. 1998. The effects of an early stressful life event on sensorimotor gating in adult rats. Schizophr Res 30:251-260.
23. Fatemi SH, Reutiman TJ, Folsom TD, Sidwell RW. The role of cerebellar genes in pathology of autism and schizophrenia. Cerebellum, in press.
24. Gould E. 1994. The effects of adrenal steroids and excitatory input on neuronal birth and survival. Ann N Y Acad Sci 743:73-92.
25. Harkany T, Guzman M, Galve-Roperh I, Berghuis P, Devi LA, Mackie K. 2007. The emerging functions of endocannabinoid signaling during CNS development. Trends Pharmacol Sci 28:83-92.
26. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC. 1991. Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. J Neurosci 11:563-583.
27. Husum H, Termeer E, Mathe AA, Bolwig TG, Ellenbroek BA. 2002. Early maternal deprivation alters hippocampal levels of neuropeptide Y and calcitonin-gene related peptide in adult rats. Neuropharmacology 42:798-806.
28. Kendler KS, Sheth K, Gardner CO, Prescott CA. 2002. Childhood parental loss and risk for first-onset of major depression and alcohol dependence: The time-decay of risk and sex differences. Psychol Med 32:1187-1194.
29. Kern JK. 2003. Purkinje cell vulnerability and autism: A possible etiological connection. Brain Dev 25:377-382.
30. Lawson A, Ahima RS, Krozowski Z, Harlan RE. 1992. Postnatal development of corticosteroid receptor immunoreactivity in the rat cerebellum and brain stem. Neuroendocrinology 55:695-707.
31. Li HP, Miki T, Yokoyama T, Lee KY, Gu H, Matsumoto Y, Wang ZY, et al. 2006. Regional differences in vulnerability of the cerebellar foliations of rats exposed to neonatal X-irradiation. Neurosci Lett 402:86-91.
32. Llorente R, Arranz L, Marco EM, Moreno E, Puerto M, Guaza C, De la Fuente M, et al. 2007. Early maternal deprivation and neonatal single administration with a cannabinoid agonist induce long-term sex-dependent psychoimmunoendocrine effects in adolescent rats. Psychoneuroendocrinology 32:636-650.
33. Macri S, Laviola G. 2004. Single episode of maternal deprivation and adult depressive profile in mice: Interaction with cannabinoid exposure during adolescence. Behav Brain Res 154:231-238.
34. Marco EM, Adriani W, Llorente R, Laviola G, Viveros MP. Detrimental psychophysiological effects of early maternal deprivation in adolescent and adult rodents. Altered responses to cannabinoid exposure. Neurosci Biobehav Rev, in press.
35. McEwen BS. 1999. Stress and hippocampal plasticity. Ann Rev Neurosci 22:105-122.
36. Mittleman G, Goldowitz D, Heck DH, Blaha CD. 2008. Cerebellar modulation of frontal cortex dopamine efflux in mice: Relevance to autism and schizophrenia. Synapse 62:544-550.
37. Morgan C, Kirkbride J, Leff J, Craig T, Hutchinson G, McKenzie K, Morgan K, et al. 2007. Parental separation, loss and psychosis in different ethnic groups: A case-control study. Psychol Med 37:495-503.
38. Navarrete M, Araque A. 2008. Endocannabinoids mediate neuron-astrocyte communication. Neuron 57:883-893.
39. Nemeroff CB. 2004. Neurobiological consequences of childhood trauma. J Clin Psychiatry 65:18-28.
40. Onaivi ES, Ishiguro H, Gong JP, Patel S, Perchuk A, Meozzi PA, Myers L, et al. 2006. Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Ann N Y Acad Sci 1074:514-536.
41. Oppenheim RW. 1991. Cell death during development of the nervous system. Annu Rev Neurosci 14:453-501.
42. Ortar G, Ligresti A, De Petrocellis L, Morera E, Di Marzo V. 2003. Novel selective and metabolically stable inhibitors of anandamide cellular uptake. Biochem Pharmacol 65:1473-1481.
43. Palmen SJ, van Engeland H, Hof PR, Schmitz C. 2004. Neuropathological findings in autism. Brain 127:2572-2583.
44. Pavlik A, Buresova M. 1984. The neonatal cerebellum: The highest level of glucocorticoid receptors in the brain. Brain Res 314:13-20.
45. Pazos MR, Nunez E, Benito C, Tolon RM, Romero J. 2005. Functional neuroanatomy of the endocannabinoid system. Pharmacol Biochem Behav 81:239-247.
46. Picard H, Amado I, Mouchet-Mages S, Olié JP, Krebs MO. 2008. The role of the cerebellum in schizophrenia: An update of clinical, cognitive, and functional evidences. Schizophr Bull 34:155-172.
47. Pisu MB, Roda E, Guioli S, Avella D, Bottone MG, Bernocchi G. 2005. Proliferation and migration of granule cells in the developing rat cerebellum: Cisplatin effects. Anat Rec A Discov Mo Cell Evol Biol 287:1226-1235.
48. Sapolsky RM. 2000. The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biol Psychiatry 48:755-765.
49. Sapolsky RM, Packan DR, Vale WW. 1988. Glucocorticoid toxicity in the hippocampus: In vitro demonstration. Brain Res 453:367-371.
50. Schmued LC, Stowers CC, Scallet AC, Xu L. 2005. Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons. Brain Res 1035:24-31.
51. Stella N. 2004. Cannabinoid signaling in glial cells. Glia 48:267-277.
52. Suárez J, Bermúdez-Silva FJ, Mackie K, Ledent C, Zimmer A, Cravatt BF, de Fonseca FR. 2008. Immunohistochemical description of the endogenous cannabinoid system in the rat cerebellum and functionally related nuclei. J Comp Neurol 509:400-421.
53. van der Stelt M, Di Marzo V. 2005. Cannabinoid receptors and their role in neuroprotection. Neuromolecular Med 7:37-50.
54. Viveros MP, Llorente R, Llorente-Berzal A, Guaza C, Lopez-Gallardo M. 2008. Early maternal deprivation in rats induces sex-dependent neurodegenerative changes in the hippocampus. FENS Abstr 4:177.13.
55. Viveros MP, Llorente R, Moreno E, Marco EM. 2005. Behavioural and neuroendocrine effects of cannabinoids in critical developmental periods. Behav Pharmacol 16:353-362.
56. Wilber AA, Southwood CJ, Sokoloff G, Steinmetz JE, Wellman CL. 2007. Neonatal maternal separation alters adult eyeblink conditioning and glucocorticoid receptor expression in the interpositus nucleus of the cerebellum. Dev Neurobiol 67:1751-1764.
57. Zani A, Braida D, Capurro V, Sala M. 2007. Delta(9)-Tetrahydrocannabinol (THC) and AM 404 protect against cerebral ischaemia in gerbils through a mechanism involving cannabinoid and opioid receptors. Br J Pharmacol 152:1301-1311.